from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2H3hEwn on May 30, 2018 at 05:49PM
National Pharmaceutical Council CSO and Executive Vice President Robert Dubois is set to participate in a panel discussion at the upcoming MedCity CONVERGE conference.
The panel session, “Promising Drugs, Pricing and Access,” is set for 10:30-11:45 a.m. July 12.
Dubois will be speaking alongside Merck Associate Vice President Patrick Davish on how pharmaceutical companies can balance research, innovation and patient affordability.
To learn more about the panel, click here.
More information about MedCity CONVERGE can be found here.